Drugs for psoriatic arthritis

Med Lett Drugs Ther. 2019 Dec 30;61(1588):203-210.
No abstract available

Keywords: Arava; Avsola; Azulfidine; Brenzys; Celebrex; Cosentyx; DMARDs; Enbrel; Erelzi; Eticovo; Gengraf; Hadima; Humira; IL-12/23 inhibitor; IL-17A inhibitors; Inflectra; Ixifi; Metoject; NSAIDs; Neoral; Olestyr; Orencia; Otezla; Otrexup; PDE4 inhibitors; Questran; Rasuvo; RediTrex; Remicade; Renflexis; Rinvoq; Salazopyrin; Simponi; Stelara; T-Cell activation inhibitor; TNF inhibitors; Taltz; Trexall; Xeljanz; abatacept; adalimumab; adverse effects; apremilast; biosimilars; celecoxib; certolizumab; cholestyramine; corticosteroids; cyclosporine; dosage; drug interactions; efficacy; etanercept; golimumab; infliximab; ixekizumab; lactation; leflunomide; methotrexate; pregnancy; psoriatic arthritis; safety; secukinumab; sulfasalazine; tofacitinib; upadacitinib; ustekinumab.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Psoriatic / drug therapy*
  • Biological Products / administration & dosage
  • Biological Products / adverse effects
  • Biological Products / therapeutic use*
  • Drug Costs
  • Drug Interactions
  • Humans
  • Phosphodiesterase 4 Inhibitors / administration & dosage
  • Phosphodiesterase 4 Inhibitors / adverse effects
  • Phosphodiesterase 4 Inhibitors / therapeutic use*

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Biological Products
  • Phosphodiesterase 4 Inhibitors